ISPAD Annual Conference Highlights Include Tzield, Kidney Disease Clinical Trial Updates
Leading diabetes researchers gathered for the annual ISPAD conference. More than 45 studies were presented by Breakthrough T1D researchers, including…
Results Are Out: Tzield Benefits Newly Diagnosed Individuals
A new study published in the New England Journal of Medicine shows Tzield can preserve beta cell health in certain…
Insulin resistance and type 1 diabetes
We take a closer look at what insulin resistance is, the risks associated with it for people with type 1…
Top Diabetes Researchers Gather for the ISPAD Annual Conference
Leading researchers from around the world will gather for the ISPAD annual conference, with more than 45 studies presented by…
EASD Meeting Brought Together World-Renowned Minds in Diabetes Research
Leading researchers gathered for the annual meeting of the European Association for the Study of Diabetes (EASD), which took place…
Top Researchers Gather for the EASD Annual Meeting
Leading researchers will gather for the annual meeting of the European Association for the Study of Diabetes, with 65 presentations…
ADCES Meeting Brings Together Health Care Specialists in Diabetes
The Association of Diabetes Care & Education Specialists (ADCES) meeting took place August 4-7, 2023, to address key issues affecting…
The Smallest Artificial Pancreas System Receives FDA Clearance
Tandem Mobi—a miniature-sized insulin pump, for use with Tandem’s Control-IQ™ technology and a compatible CGM—received FDA clearance.
At ADA 2023, Breakthrough T1D-Funded Research Takes Center Stage (with a “Happy Hour” by Dr. Aaron Kowalski)
Breakthrough T1D joined thousands at the ADA's Scientific Sessions, where experts presented significant advancements in diabetes research and clinical trials.
